Literature DB >> 14139995

OBSERVATIONS ON THE ETIOLOGY AND THERAPY OF "BRITTLE" DIABETES.

G D MOLNAR.   

Abstract

Salient aspects of prolonged metabolic studies on seven excessively labile diabetic patients and a review of the literature concerning causation and therapy of brittle diabetes are presented. Brittleness is redefined as "a syndrome of excessive insulin-sensitivity and ketosis-proneness manifested by extreme and unexplainable short-term and long-term fluctuations in the parameters of the disease". Evidence on the causation of hyperlability points to dysfunction of plasma-protein transport and of hepatic and peripheral tissue metabolism of insulin. No objectively demonstrable complete and lasting stabilization was possible by means of any antidiabetic or adjunctive therapeutic measures. However, achievement of quantitative improvement in the accuracy of regulation of diabetes and moderation in deviations from the acceptable range of parameters were feasible. To this end, therapy recommended for everyday use incorporates the following principles found to be most helpful in following the oscillations of the disease on the research ward: flexibility in the plan of therapy; accuracy, especially in timing of therapeutic events; and employment of an insulin program best suited to the patient's needs and comfort.

Entities:  

Keywords:  ACIDOSIS, DIABETIC; ANTIDIABETICS; BLOOD PROTEINS; DIABETES MELLITUS; INSULIN; PREGNANCY; PREGNANCY IN DIABETES

Mesh:

Substances:

Year:  1964        PMID: 14139995      PMCID: PMC1922623     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  12 in total

1.  Clinical impact of insulin.

Authors:  H RIFKIN
Journal:  Diabetes       Date:  1963 Jan-Feb       Impact factor: 9.461

2.  Rate of clearance of insulin labelled with 131 I from the subcutaneous tissues in normal and diabetic subjects.

Authors:  C L JOINER
Journal:  Lancet       Date:  1959-05-09       Impact factor: 79.321

3.  Effects of therapeutic measures in a hyperlabile diabetic.

Authors:  G D MOLNAR; W F MCGUCKIN; J L STRIEBEL; C F GASTINEAU
Journal:  Proc Staff Meet Mayo Clin       Date:  1961-02-01

4.  Quantitative aspects of the reaction between insulin and insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

5.  Peripheral glucose metabolism in fasting control subjects and diabetic patients.

Authors:  W J BUTTERFIELD; H E HOLLING
Journal:  Clin Sci       Date:  1959-05       Impact factor: 6.124

6.  Plasma insulin activity after glucose: an index of insulogenic reserve in normal and diabetic man.

Authors:  H S SELTZER; W L SMITH
Journal:  Diabetes       Date:  1959 Nov-Dec       Impact factor: 9.461

7.  Studies on the kinetics of glucose utilization.

Authors:  H ELRICK; C J HLAD; T A WITTEN
Journal:  J Clin Invest       Date:  1956-10       Impact factor: 14.808

8.  Treatment of diabetes selection of technic according to severity.

Authors:  A R COLWELL
Journal:  Diabetes       Date:  1953 Jul-Aug       Impact factor: 9.461

9.  Distribution and degradation studies with insulin I131.

Authors:  N J ELGEE; R H WILLIAMS; N D LEE
Journal:  J Clin Invest       Date:  1954-09       Impact factor: 14.808

10.  Importance of life stress in course and management of diabetes mellitus.

Authors:  L E HINKLE; S WOLF
Journal:  J Am Med Assoc       Date:  1952-02-16
View more
  7 in total

1.  [Effects of the intravenous infusion of nicotinic acid on blood concentrations of substrates, metabolites and hormones in juvenile-onset diabetes].

Authors:  D Michaelis; H J Hahn; R Michael; H Schäfer; S Knospe; E Jutzi; P Wulfert
Journal:  Diabetologia       Date:  1970-12       Impact factor: 10.122

2.  The brittle diabetic.

Authors:  W L Henry
Journal:  J Natl Med Assoc       Date:  1969-11       Impact factor: 1.798

3.  Brittle diabetes.

Authors:  R Tattersall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-31

4.  Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.

Authors:  J C Pickup; P D Home; R W Bilous; H Keen; K G Alberti
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31

Review 5.  Spectrum of diabetic neuropathies.

Authors:  Hideyuki Sasaki; Nobutoshi Kawamura; Peter J Dyck; P James B Dyck; Mikihiro Kihara; Phillip A Low
Journal:  Diabetol Int       Date:  2020-01-08

6.  The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes.

Authors:  J A Lutterman; T J Benraad; A van 't Laar
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

7.  Glucose variability.

Authors:  F John Service
Journal:  Diabetes       Date:  2013-05       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.